Ticker LaunchRegulation A · Tier 2
CancerVAX, Inc.
CancerVAX, Inc. filed a Tier 2 Regulation A offering statement (Form 1-A) on Dec 8, 2023 for up to $5M at $2.10 per security. The SEC qualified the offering on Mar 22, 2024.
- Status
- Qualified
- Tier
- Tier 2
- Offering size
- $5M
- Offer price
- $2.10
- Security type
- Equity (common or preferred stock)
- Filed
- Dec 8, 2023
- Qualified
- Mar 22, 2024
- Industry
- Pharmaceutical Preparations
- State
- CA
More on this offering for subscribers
- Revenue, net income and total assets from the offering statement
- Employees
- Market cap at the offer price
- Auditor
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Offering statement (Form 1-A) Dec 8, 2023
- All filings on EDGAR CIK 1905495
Other qualified Biotech & pharma Reg A offerings
- Bioquest CorpAug 21, 2024 · $10M
- Adia Med, Inc.Jun 21, 2024 · $938K
- CBD Life Sciences Inc.Jun 21, 2024 · $10.1M
- IntelGenx Technologies Corp.Feb 16, 2024 · $20M
- SciMar Ltd.Dec 21, 2023 · $55M
- Starpax Biopharma Inc.Sep 11, 2023 · $24M